Epithelial histocompatibility locus antigen (HLA) class II expression was studied to evaluate its induction by mucosal mononuclear cells in inflammatory bowel disease and to characterise the responsible cytokine. Unstimulated cells of the HT-29 epithelial cell line did not produce class II molecules. After being stimulated with the mitogenic lectin phytohaemagglutinin mucosal mononuclear cells released a cytokine that induced epithelial HLA-DR expression. The cytokine had the physicochemical and immunological characteristics of interferon-y, and no additional cytokines were detected.
The expression of major histocompatibility complex antigen-class II molecules by non-lymphoid cells is well recognised.IA The function of these molecules remains the subject of debate.5 It has been claimed that epithelial cells expressing class II histocompatibility molecules can act as antigen presenting cells to T cells.67 It has been suggested that normally, epithelial cells present antigen to CD8+antigen specific suppressor cells,8 or antigen non-specific suppressor cells.6 Normal murine enterocytes however, have been shown to present soluble antigen in a class II restricted fashion to an antigen specific T cell hybridoma producing interleukin-2. 9 Mayer has further shown that enterocytes from idiopathically inflamed intestine may support the proliferation ofCD4+ cells unrelated to the level of HLA-DR expression, and suggest that in idiopathic inflammatory bowel disease there is an inability to present antigen to antigen non-specific T suppressor cells.'0 In inflammatory bowel diseases such as ulcerative colitis and Crohn's disease there is evidence ofactivation of immunological effector mechanisms in the mucosa. " It is not clear if the activated immunological processes are an appropriate response to an as yet unidentified pathogen or a pathologically increased response to a relatively otherwise innocent challenge. An increase in colonic epithelial cell class II histocompatibility locus antigen expression has been noted in both ulcerative colitis and Crohn's disease when in relapse.212 14 Interferon (U/ml) (Fig  1) . Maximal expression occurred at a dose of 10 U/ml interferon-y. Higher doses produced a decrease in the amount of cellular protein/well in the ELISA and immunohistochemical studies confirmed that higher doses of interferon-y did not cause an increase in expression but a significant cytopathic effect was exerted (Fig 2a, b) .
INDUCTION BY MUCOSAL MONONUCLEAR CELL CULTURE SUPERNATANTS
Supernatants obtained from the culture of unstimulated mucosal cells did not produce any detectable induction of HLA-DR molecules despite the assay being able to detect 2 U/ml interferon-y. The supernatants obtained from the culture of phytohaemagluttinin stimulated cells all induced detectable quantities of HLA-DR molecules, but there was no evidence of either increased or decreased production of cytokine differences between patients with ulcerative colitis and Crohn's disease and controls (Fig 3) . Phytohaemagglutinin alone did not induce class II antigen expression. Exposure of the supernatants to pH 2 or boiling for 30 minutes destroyed all class II inducing ability (Fig 4) . The testing of individual fractions generated by the gel column suggested that the molecular weight of the active fraction was in the region of 20-25 kD (Fig 5) . Incubation ofthe pooled supernatant with antiserum to interferon-y resulted in abrogation of class II induction. At a dilution ofthe antiserum of 1:100 class II induction was not detectable. The abrogation paralleled that seen with interferon-y, suggesting that there was not an agent other than interferon-y present in the supernatant that induced class II expression (Fig 6) .
Discussion
This work confirms the work of others that human colonic epithelial cell line can be induced to express HLA class II proteins by recombinant interferon-y.'8 This occurs in a dose dependent manner up to a concentration of 10 U/ml. Higher concentrations of interferon-y produce a significant cytopathic effect. These concentrations are much lower than have previously observed to be effective.'8 However previous studies employed a plasmid derived recombinant interferon-y whereas the product employed here was a culture supernatant of a Chinese hamster ovary cell line transfected with the human interferon-y gene, had thus undergone eukaryotic glycosylation and hence potentially different biological activities.
Supernatants from unstimulated mucosal mononuclear cell culture did not produce any significant induction of epithelial class II molecules whereas after phytohaemagglutinin stimulation a significant amount was induced. Spontaneous and stimulated interferon-y production by lamina propria lymphocytes in Crohn's disease has recently been studied. 9 Using an antiviral bioassay for interferon activity and antisera to interferons a and 1, spontaneous production of interferon-y was observed in Crohn's disease. It is possible that the epithelial cell HLA-DR induction assay is less sensitive for detecting interferon activity than the antiviralbioassay which may explain the differences between these results. No significant differences in HLA-DR induction were obtained using supernatants derived from patients with ulcerative colitis, Crohn's disease. or controls.
The lack of class II induction by cells isolated from inflamed tissue may be considered surprising as the epithelium in cases of inflammatory bowel disease is strikingly HLA-DR positive,'2 but is in accord with observations on interferon-y production by isolated mucosal mononuclear cells. There is a debate about spontaneous mucosal mononuclear cells production of interferon-y. 920 Stimulation of mucosal mononuclear cells by PHA or recombinant interleukin-2-, however, has been shown to induce production of interferon-y.2o In these studies decreased amounts of cytokine inducing monocyte HLA-DR and interferon-y were produced by cells isolated from patients with inflammatory bowel disease. At first sight the results presented here may seem to be discordant with those of Ouyang et al, but the methodology used is quite different. The experiments that are described here quantify the induction of epithelial class II HLA molecules, not the amount of interferon-y.
There may be significant amounts of interferon-a or interferon-f activity in the supernatant which is indistinguishable from interferon-y in a bioassay.
Ouyang et al used monocytes as model cells for class II induction, and there may be differences between monocyte and epithelial cell lines in induction of class II HLA molecules. There is evidence that many cytokines including interleukin-4, granulocytes macrophage colony stimulating factor and tumour necrosis factor-a may act to increase class II molecule expression,23 and synergism between interferon-y and tumour necrossis factor-a has been shown for HT-29 cells. 2425 The immunohistological evidence does not suggest that there is a defect in epithelial class II induction in the colon. All the studies reported thus far show extensive epithelial class II induction in ulcerative colitis and Crohn's disease and no qualitative difference from induction seen in inflammatory controls.2 12 25 The biological and physicochemical properties of the factor in the supernatants are consistent with it being interferon-y. Human interferon-y is usually shown to have a molecular weight of about 55 kD, and this has been found to be dimeric with components of 20 and 25 kD.2' The activity in the supernatants is acid labile, has a molecular weight of about 22 kD, and is completely neutralised by antiserum to human interferon-y. Thus it is possible that the monomeric forms are being detected in these fractions.
Unlike studies using circulating lymphocytes we could not detect any evidence of any class II including factor other than interferon-y.27 Several explanations for this difference are possible. The assay of class II molecules may be too insensitive, although it was possible to detect the effect of 2 U/ml interferon-y above background. Epithelial cells may not be susceptible to the same range of cytokines that induce class II HLA molecules on circulating T cells. It is probable that mucosal mononuclear cells do not produce the same range of cytokines as produced by the circulating mononuclear cell population.
The responses measured here may be a selective in vitro response to phytohaemagluttinin and may not represent the in vivo situation.
In conclusion, mucosal mononuclear cells of both 'normal' and inflamed colon have the potential to produce cytokines that induce epithelial cell class II molecules. These are, however, only produced after mitogenic stimulation ofthe cells. The cytokine responsible has the characteristics of interferon-y.
